BioLink Life Sciences Inc Profile last edited on: 10/3/17
CAGE: 1WR74
UEI: GUSQRGKRZ4C9
Business Identifier: analytical chemistry, medicinal chemistry, and process development support 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 04
County: Wake
Congr. District: 04
County: Wake
Public Profile
BioLink Life Sciences, Inc., a biotechnology and life sciences company, provides contract research and development support services to pharmaceutical and biotech companies. The company's services include analytical, medicinal chemistry, and process development support; and project management, technical assessments, and intellectual property assessments and support. It also engages in reformulating drugs to reduce side effects and enhance their safety and patient tolerability and works with pharmaceutical partners to commercialize, market, and distribute its drug candidates.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
10-14Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2012 | 1 | NIH | $94,935 | |
| Project Title: Low Molecular Weight Iron Chelate For Treatment Of Anemia Of Inflammation | ||||
| 2012 | 1 | USDA | $97,215 | |
| Project Title: Enhanced hemoglobin production in neonatal piglets with FCP, a low molecular weight iron chelate | ||||
| 2012 | 1 | USDA | $97,215 | |
| Project Title: Enhanced Hemoglobin Production in Neonatal Piglets with FCP, a Low Molecular Weight Iron Chelate | ||||
| 2011 | 1 | NIH | $146,080 | |
| Project Title: Sbir Topic Nccam: 001 R And Rs-Alpha-Lipoic Acid Analytical Methods Validation | ||||
| 2010 | 1 | NIH | $194,509 | |
| Project Title: Novel Phosphate Binder: Effects on Hyperphosphatemia, Vascular Calcification & Bo | ||||
Key People / Management
Deanna J Nelson -- President and Chief Scientific Officer
Walter C Holberg
Jie Li -- Synthesis & Process Development Support
Deanna J Nelson
Diana Nelson
R K Seetharama
Walter C Holberg
Jie Li -- Synthesis & Process Development Support
Deanna J Nelson
Diana Nelson
R K Seetharama
Company News
There are no news available.
